Safety and efficacy of drug-eluting beads versus conventional bronchial arterial chemoembolization for lung cancer: a systematic review and meta-analysis - Takeaways - MDSpire

Comparative Analysis of Drug-Eluting Beads and Standard Bronchial Arterial Chemoembolization for Lung Cancer: A Systematic Review and Meta-Analysis

  • By

  • Zezhong Gong

  • Yali Liu

  • Yusheng Song

  • Xinghai Li

  • Yunfei Tian

  • Jing Li

  • Chaoyi Qi

  • July 21, 2026

Share

  • 1

    DEB-BACE showed higher pooled objective response rates (ORR) at 1-3 months and 6 months compared to conventional bronchial arterial chemoembolization (cBACE).

  • 2

    The disease control rate (DCR) was also significantly higher for DEB-BACE at both 1-3 months and 6 months compared to cBACE.

  • 3

    No significant differences were found between DEB-BACE and cBACE regarding adverse events like hemoptysis, fever, or nausea.

  • 4

    The systematic review included five studies from China with a total of 221 patients, focusing on the efficacy and safety of DEB-BACE versus cBACE.

  • 5

    Findings suggest that DEB-BACE may provide better short-term tumor response, but further multicenter randomized trials are needed for confirmation.

Original Source(s)

Safety and efficacy of drug-eluting beads versus conventional bronchial arterial chemoembolization for lung cancer: a systematic review and meta-analysis

  • by Zezhong Gong, Yali Liu, Yusheng Song, Xinghai Li, Yunfei Tian, Jing Li, Chaoyi Qi

  • July 21, 2026

Related Content

Outcomes following different thermal ablation strategies in patients with oligometastatic colorectal lung metastases

Sequential tislelizumab plus bronchial arterial chemoembolization and systemic chemotherapy in advanced NSCLC with bulky tumors: efficacy and safety

Datopotamab deruxtecan in solid tumors: Recent research progress and clinical applications